Company intelligence / Profile preview
SK Life Science, Inc.
Paramus, NJ, USAsklifescienceinc.com ↗
- Ownership
- Private
- Employees
- ~282
- Development stage
- Commercial
01
Overview
SK Life Science has successfully commercialized cenobamate for epilepsy in the U.S. and has a robust pipeline of eight compounds targeting CNS disorders and oncology. Clinical-stage assets span from Phase 1 through Phase 3 trials across multiple indications including epilepsy subtypes and psychiatric/neurodevelopmental disorders. The company leverages both traditional small molecule approaches as well as next-generation targeted protein degradation technologies via its labs subsidiary.
- Therapeutic areas
- OncologyPsychiatryNeurology
- Modalities
- Small moleculesTargeted protein degraders
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Clinical development partnerships noted for some assets but no major disclosed pharma co-development deals found.
Beyond the preview
Go deeper on SK Life Science, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SK Life Science, Inc..